US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.951
- +0.056+6.26%
Close Oct 4 16:00 ET
- 0.928
- -0.023-2.43%
Post 16:09 ET
243.21MMarket Cap-2641P/E (TTM)
0.964High0.890Low730.19KVolume0.900Open0.895Pre Close681.31KTurnover0.43%Turnover RatioLossP/E (Static)255.75MShares2.05052wk High2.53P/B162.19MFloat Cap0.42052wk Low--Dividend TTM170.55MShs Float21.570Historical High--Div YieldTTM8.24%Amplitude0.420Historical Low0.933Avg Price1Lot Size
Adaptimmune Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Sep 30, 2024
The average Adaptimmune Therapeutics stock price target is 2.36 with a max estimate of 4.00 and a min estimate of 1.00
Review Adaptimmune Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Sep 30, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
